← All organizations

Hepatera Ltd.

For profitWebsite ↗

Also known as: Hepatera Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 15, 2019

Defunct as of Dec 12, 2024

Timeline

2010s

Jun 1, 2011
Hepatera Ltd.— Founded

2020s

Dec 12, 2024
Hepatera Ltd.— Defunct

Drugs by trial phase (6 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

bulevirtide

Phase 2 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (6)

NCT03852433CollaboratorPhase 2Apr 15, 2019
NCT03852719CollaboratorPhase 3Apr 15, 2019
NCT02888106Lead sponsorPhase 2Apr 1, 2016
NCT03546621Lead sponsorPhase 2Feb 16, 2016
NCT02637999Lead sponsorPhase 1/Phase 2Mar 1, 2014
NCT02881008Lead sponsorPhase 1/Phase 2Aug 1, 2012

Details

Founded: Moscow, RU Jun 1, 2011
Last known activity: Apr 15, 2019